News in the Life Sciences Industry

YONGIN, South Korea, Sept. 30, 2018 /PRNewswire/ -- GC Pharma (formerly known as Green Cross) announced today it has received approval from the South Korean Ministry of Food and Drug Safety (MFDS) expanding the indication for GCFLU Quadrivalent(TM) (Seasonal Influenza Vaccine) to include use... Read more ››

UPPSALA, Sweden, Oct. 1, 2018 /PRNewswire/ -- Orexo AB (publ) today announces that the field representatives in the contracted field force have been offered direct employment with Orexo US Inc. starting October 1, 2018. The decision follows on the positive outcome in the patent litigation against... Read more ››

STOCKHOLM, Oct. 1, 2018 /PRNewswire/ -- Cantargia AB today announces that the United States Patent and Trademark Office (USPTO) has granted the company's patent application 15/501,710 directed to the antibody CAN03, which is of relevance for Cantargia's CANxx project. The patent number is... Read more ››

STOCKHOLM, Oct. 1, 2018 /PRNewswire/ -- The shareholders of IRRAS AB ("IRRAS"), a commercial-stage medical-technology company focused on developing and commercializing innovative solutions for various brain pathologies, voted to approve Eva Nilsagard as new member of the Group's board... Read more ››

LUND, Sweden, Sept. 28, 2018 /PRNewswire/ -- Immunovia announced recently that a new study confirms that IMMray(TM) blood test successfully addresses one of the major challenges in autoimmune testing.

LUND, Sweden, Sept. 28, 2018 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy, will present preclinical safety data for the drug candidate ATOR-1017 at the 4th CRI-CIMT-EATI-AACR... Read more ››

LUND, Sweden, Sept. 27, 2018 /PRNewswire/ -- Hansa Medical AB (NASDAQ Stockholm: HMED), the leading biopharma company focusing on inhibition of immunoglobulin G (IgG)-mediated immunopathologies, announced today the successful completion of two Phase 2 clinical studies of imlifidase for kidney... Read more ››

STOCKHOLM, Sept. 27, 2018 /PRNewswire/ -- IRRAS AB (NASDAQ Stockholm: IRRAS) announced today that it has added key talent to its commercial organization to drive sales of the company's lead product, IRRAflow®, in the United States. Steve Crowell, John Gessert, Anthony Maestas,... Read more ››

GÖTHENBURG, Sweden, Sept. 25, 2018 /PRNewswire/ -- Capio today announces the notice of the Extraordinary General Meeting (the "EGM") convened to resolve on the Board's proposal to approve the sale of Capio France. The EGM will be held at 4.00 p.m. CEST on 18 October 2018. Capio also announces... Read more ››

STOCKHOLM, Sept. 25, 2018 /PRNewswire/ -- Calliditas Therapeutics AB (publ) ("Calliditas") today announced that post-hoc results from its clinical Phase 2b study NEFIGAN will be presented in an oral session at the International IgA Nephropathy Network meeting (IIgANN) in Buenos Aires, Argentina,... Read more ››

GOTHENBURG, Sweden, Sept. 25, 2018 /PRNewswire/ -- The shareholders of Capio AB are hereby invited to attend the Extraordinary General Meeting (the "Meeting") for the primary purpose of resolving on an approval of the proposed sale of Capio Santé SA. The Meeting will be held at Mannheimer... Read more ››

LUND, Sweden, Sept. 21, 2018 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use, CHMP, has adopted a positive opinion recommending approval of Buvidal® (buprenorphine) prolonged-release solution for injection... Read more ››